Michael Daneshvar

Dr. Michael Daneshvar

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 July 2014 in Advances in Medicine
Verified
Journal Article
Open access
PDF file
AGAaron Gipsman
Aaron Gipsman
LRLisa Rauschert
Lisa Rauschert
MDMichael Daneshvar
Michael Daneshvar
PKPatrick T Knott
Patrick T Knott
The Formetric 4D dynamic system (Diers International GmbH, Schlangenbad, Germany) is a rasterstereography based imaging system designed to evaluate spinal deformity, providing radiation-free imaging of the position, rotation, and shape of the spine during the gait cycle.Purpose.This study was designed to evaluate whether repeated measurements with the Formetric 4D dynamic system would be reproducible with a standard deviation of less than +/− 3 degrees. This study looked at real-time segmental motion, measuring kyphosis, lordosis, trunk length, pelvic, and T4 and L1 vertebral body rotation.Methods.Twenty healthy volunteers each underwent 3 consecutive scans. Measurements for kyphosis, lordosis, trunk length, and rotations of T4, L1, and the pelvis were recorded for each trial.Results.The average standard deviations of same-day repeat measurements were within +/− 3 degrees with a range of 0.51 degrees to 2.3 degrees.Conclusions.The surface topography system calculated reproducible measurements with error ranges comparable to the current gold standard in dynamic spinal motion analysis. Therefore, this technique should be considered of high clinical value for reliably evaluating segmental motion and spinal curvatures and should further be evaluated in the setting of adolescent idiopathic scoliosis.

30 September 2024 in Cancers
Verified
Journal Article
Open access
PDF file
FMFarshad Sheybaee Moghaddam
Farshad Sheybaee Moghaddam
SDSami Dwabe
Sami Dwabe
NMNataliya Mar
Nataliya Mar
LSLeila Safdari
Leila Safdari
NSNavin Sabharwal
Navin Sabharwal
AKArash Rezazadeh Kalebasty
Arash Rezazadeh Kalebasty
Radical cystectomy with lymph node dissection and urinary diversion is the gold-standard treatment for non-metastatic muscle-invasive bladder cancer (MIBC). However, in patients who refuse cystectomy, or in whom cystectomy carries a high risk, bladder-preserving therapies remain potential options. Bladder preservation therapies can include maximal debulking transurethral resection of bladder tumor (TURBT), concurrent chemoradiation therapy, followed by cystoscopy to assess response. At this time, maximal TURBT is recommended for patients prior to the initiation of chemoradiation therapy or in patients with residual bladder tumors after the completion of chemoradiation therapy. That being said, TURBT carries significant risks such as bladder perforation, bleeding, and infection, ultimately risking delayed systemic treatment. Hence, understanding its role within trimodal therapy is crucial to avoid undue suffering in patients. Herein, we review the current literature on the impact of debulking TURBT in non-metastatic MIBC.

26 April 2025 in Urology
Verified
Journal Article
Open access
RDRyan J. Davis
Ryan J. Davis
APAsher C. Park
Asher C. Park
MFMilan P. Fehrenbach
Milan P. Fehrenbach
NSNavin Sabharwal
Navin Sabharwal
MDMichael Daneshvar
Michael Daneshvar
To assesses the relationship between county-level social vulnerability and the distribution of urologists across the United States (US) using the Social Vulnerability Index (SVI), a tool that scores counties based on social determinants of health. This is an ecologic study that uses publicly available datasets on number and locations of urologists within the US. The SVI scores counties in terms of their overall social vulnerability and social vulnerability across the following four subthemes: socioeconomic status, race/ethnic minority status, household characteristics, and housing type and transportation. Using these scores, we evaluated associations between county-level social vulnerability and county urologist presence/absence, density, and distance. Higher county vulnerability in socioeconomic status was significantly associated with higher likelihood of urologist absence (OR=1.59, 95% CI=[1.20, 2.11]) and lower urologist density (β= -0.65, 95% CI=[-1.18, -0.12]). Similarly, higher vulnerability in household characteristics was associated with higher likelihood of urologist absence (OR=2.13, 95% CI=[1.61, 2.81]) and lower urologist density (β=-1.51, 95% CI=[-2.03, -0.99]). Higher overall SVI scores and all subtheme scores were significantly associated with increased county miles to nearest urologist with the largest effect seen for overall SVI (β=10.85, 95% CI=[8.06, 13.64]). Using the SVI, we found that counties more socially vulnerable in socioeconomic status and household characteristics have significantly less access to urologists. Our findings suggest that the SVI can be used as a tool to locate socially vulnerable counties lacking access to urologic care, and thus could potentially guide policy aimed at advancing equitable urologic access across the US.

1 January 2022 in Journal of Urology
Verified
Journal Article
Closed access
CWCheyenne Williams
Cheyenne Williams
MAMichael Ahdoot
Michael Ahdoot
MDMichael Daneshvar
Michael Daneshvar
CHChristian Hague
Christian Hague
AWAndrew R. Wilbur
Andrew R. Wilbur
PPPeter A. Pinto
Peter A. Pinto


Verified
Journal Article
Open access
PDF file
MDMohammad Ghassab Deameh
Mohammad Ghassab Deameh
WSWafika A. M. SulimanThaher
Wafika A. M. SulimanThaher
RARahma AlMari
Rahma AlMari
Omar MustafaOmar Mustafa
Omar Mustafa
QAQutiba Alwreikat
Qutiba Alwreikat
Mohammed ShahaitMohammed Shahait
Mohammed Shahait
Background/Objectives: Prostate biopsy is essential for diagnosing prostate cancer. Social determinants of health (SDOH), including socioeconomic status, race, occupation, education, and environment, affect access, outcomes, and quality of life. Recognizing disparities from technology access to complications is crucial for equitable care. A systematic review examined how SDOH impacts biopsy access, technology, and complications. Methods: A systematic search of PubMed, Web of Science, and Scopus was performed to identify eligible studies published through February 2026. We included studies that evaluated the association between one or more SDOHs and prostate biopsy. Relevant outcomes included biopsy utilization, use of specific biopsy technologies (e.g., magnetic resonance imaging (MRI)-guided, transperineal), and post-procedural complications. Results: Nine observational studies met the inclusion criteria. The findings revealed disparities across three key domains. First, access to advanced biopsy technology was uneven. Four studies showed that Black men were significantly less likely than White men to receive MRI-guided biopsies. Additionally, post-biopsy outcomes showed that Black and Hispanic men faced significantly higher rates of post-biopsy infection and hospitalization compared to White men. Lastly, patients in rural areas, those in public hospitals, and individuals with lower socioeconomic status demonstrated reduced access to modern techniques, including MRI-guided or transperineal biopsy. Conclusions: Social and economic factors influence who receives a prostate biopsy and who has access to advanced technologies. Minority and low-income patients face diagnosis barriers and higher complication rates, highlighting systemic inequities. The healthcare system often rewards access over need, and without bold policy changes, gaps in technology and resources will worsen, moving us further from truly equitable prostate cancer care.